Andra AP-fonden’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.2M | Sell |
48,030
-54,650
| -53% | -$16.2M | 0.17% | 149 |
|
|
2025
Q4 | $28M | Sell |
102,680
-42,620
| -29% | -$11.6M | 0.35% | 82 |
|
|
2025
Q3 | $39.3M | Buy |
145,300
+77,100
| +113% | +$21M | 0.5% | 48 |
|
|
2025
Q2 | $18.8M | Buy |
+68,200
| New | +$18.5M | 0.26% | 130 |
|
|
2025
Q1 | – | Sell |
-18,700
| Closed | -$4.34M | – | 474 |
|
|
2024
Q4 | $4.34M | Buy |
18,700
+2,100
| +13% | +$483K | 0.07% | 299 |
|
|
2024
Q3 | $3.66M | Sell |
16,600
-26,200
| -61% | -$5.42M | 0.05% | 327 |
|
|
2024
Q2 | $8.41M | Buy |
42,800
+34,900
| +442% | +$7.21M | 0.14% | 229 |
|
|
2024
Q1 | $1.7M | Sell |
7,900
-28,200
| -78% | -$5.92M | 0.03% | 342 |
|
|
2023
Q4 | $7.6M | Buy |
36,100
+4,900
| +16% | +$1.05M | 0.4% | 115 |
|
|
2023
Q3 | $6.25M | Buy |
31,200
+1,600
| +5% | +$318K | 0.37% | 122 |
|
|
2023
Q2 | $5.48M | Buy |
29,600
+1,300
| +5% | +$240K | 0.14% | 350 |
|
|
2023
Q1 | $5.42M | Sell |
28,300
-6,600
| -19% | -$1.19M | 0.14% | 321 |
|
|
2022
Q4 | $5.87M | Sell |
34,900
-3,100
| -8% | -$539K | 0.18% | 259 |
|
|
2022
Q3 | $6.73M | Buy |
38,000
+16,100
| +74% | +$3.18M | 0.22% | 183 |
|
|
2022
Q2 | $4.48M | Buy |
+21,900
| New | +$4.64M | 0.13% | 363 |
|
|
2021
Q4 | $6.12M | Sell |
26,800
-9,500
| -26% | -$2.09M | 0.12% | 370 |
|
|
2021
Q3 | $7.02M | Sell |
36,300
-6,000
| -14% | -$1.22M | 0.14% | 344 |
|
|
2021
Q2 | $9M | Buy |
42,300
+800
| +2% | +$169K | 0.18% | 243 |
|
|
2021
Q1 | $8.48M | Sell |
41,500
-5,800
| -12% | -$1.14M | 0.19% | 237 |
|
|
2020
Q4 | $8.61M | Sell |
47,300
-14,300
| -23% | -$2.43M | 0.19% | 229 |
|
|
2020
Q3 | $10.3M | Buy |
61,600
+12,900
| +26% | +$2.17M | 0.28% | 58 |
|
|
2020
Q2 | $7.92M | Buy |
48,700
+11,800
| +32% | +$2.12M | 0.23% | 80 |
|
|
2020
Q1 | $6.38M | Buy |
36,900
+10,900
| +42% | +$2.17M | 0.23% | 55 |
|
|
2019
Q4 | $5.22M | Buy |
26,000
+300
| +1% | +$61.5K | 0.15% | 349 |
|
|
2019
Q3 | $5.43M | Buy |
25,700
+1,300
| +5% | +$272K | 0.16% | 304 |
|
|
2019
Q2 | $4.74M | Sell |
24,400
-2,200
| -8% | -$406K | 0.14% | 394 |
|
|
2019
Q1 | $4.38M | Buy |
+26,600
| New | +$4.7M | 0.13% | 426 |
|
|
2018
Q3 | $6.01M | Sell |
35,300
-6,800
| -16% | -$1.14M | 0.15% | 304 |
|
|
2018
Q2 | $6.9M | Buy |
42,100
+2,600
| +7% | +$425K | 0.19% | 198 |
|
|
2018
Q1 | $6.39M | Sell |
39,500
-29,156
| -42% | -$4.64M | 0.17% | 268 |
|
|
2017
Q4 | $10M | Sell |
68,656
-11,044
| -14% | -$1.57M | 0.23% | 123 |
|
|
2017
Q3 | $10.8M | Buy |
79,700
+11,900
| +18% | +$1.5M | 0.25% | 107 |
|
|
2017
Q2 | $8.49M | Buy |
67,800
+2,400
| +4% | +$287K | 0.21% | 134 |
|
|
2017
Q1 | $7.77M | Sell |
65,400
-3,000
| -4% | -$361K | 0.18% | 142 |
|
|
2016
Q4 | $7.89M | Buy |
68,400
+28,800
| +73% | +$3.2M | 0.22% | 126 |
|
|
2016
Q3 | $4.14M | Sell |
39,600
-5,300
| -12% | -$553K | 0.11% | 288 |
|
|
2016
Q2 | $4.37M | Buy |
44,900
+4,800
| +12% | +$454K | 0.11% | 262 |
|
|
2016
Q1 | $3.85M | Sell |
40,100
-4,900
| -11% | -$446K | 0.1% | 302 |
|
|
2015
Q4 | $4.08M | Buy |
45,000
+5,500
| +14% | +$518K | 0.12% | 251 |
|
|
2015
Q3 | $3.66M | Sell |
39,500
-4,600
| -10% | -$437K | 0.11% | 280 |
|
|
2015
Q2 | $4.1M | Buy |
44,100
+8,400
| +24% | +$784K | 0.12% | 263 |
|
|
2015
Q1 | $3.38M | Sell |
35,700
-2,900
| -8% | -$269K | 0.1% | 325 |
|
|
2014
Q4 | $3.42M | Buy |
38,600
+33,100
| +602% | +$2.8M | 0.08% | 365 |
|
|
2014
Q3 | $440K | Hold |
5,500
| – | – | 0.01% | 536 |
|
|
2014
Q2 | $390K | Sell |
5,500
-52,200
| -90% | -$3.67M | 0.01% | 552 |
|
|
2014
Q1 | $4.27M | Buy |
57,700
+17,200
| +42% | +$1.3M | 0.1% | 336 |
|
|
2013
Q4 | $3.18M | Buy |
40,500
+4,400
| +12% | +$345K | 0.08% | 371 |
|
|
2013
Q3 | $2.67M | Buy |
36,100
+15,300
| +74% | +$1.13M | 0.07% | 385 |
|
|
2013
Q2 | $1.58M | Buy |
+20,800
| New | +$1.36M | 0.04% | 452 |
|
Other funds holding CME
Andra AP-fonden's CME Position: Q1 2026 in Review
Andra AP-fonden reduced its CME Group (CME) stake by 53% in Q1 2026, selling an estimated $16.2M and leaving 48,030 shares worth $14.2M. The position accounts for 0.17% of the portfolio, ranked #149.
Andra AP-fonden first reported a position in CME in Q2 2013 and has held it in 49 quarters since. The position peaked at $39.3M in Q3 2025. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Andra AP-fonden held 48,030 shares of CME Group worth $14.2M as of Q1 2026.
- Andra AP-fonden sold 54,650 CME Group shares in Q1 2026, an estimated $16.2M.
- CME Group made up 0.17% of Andra AP-fonden's portfolio in Q1 2026, its #149 holding.
- Andra AP-fonden first reported a position in CME Group in Q2 2013 and has held it in 49 quarters since.
- Andra AP-fonden's CME Group position peaked at $39.3M in Q3 2025.
- 1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.